Kennedy’s vaccine overhaul turns public-health uncertainty into commercial risk
Full analysis for subscribers
TUESDAY, JULY 14, 2026
Interview-ready insights. Three minutes to read.
Subscribers get the mechanism behind every story, plus the full archive. Three points every weekday. £5 a month, cancel anytime.
Subscribe →Already a subscriber? Log in